Fate Therapeutics
FATE
#8160
Rank
C$0.27 B
Marketcap
$2.41
Share price
1.20%
Change (1 day)
-46.79%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$2.94

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.12. In 2022 the company made an earnings per share (EPS) of -$4.18 a decrease over its 2021 EPS that were of -$3.20.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.94-29.75%
2022-$4.1830.49%
2021-$3.207.21%
2020-$2.9945.45%
2019-$2.0519.17%
2018-$1.7217.65%
2017-$1.46-3.77%
2016-$1.52-12.4%
2015-$1.74-3.97%
2014-$1.81-2.09%
2013-$1.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$11.24 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.97-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$12.42 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.45 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.81-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA